Panagora Asset Management’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,752
Closed -$117K 2513
2019
Q3
$117K Sell
4,752
-8,639
-65% -$263K ﹤0.01% 1784
2019
Q2
$472K Sell
13,391
-74,978
-85% -$2.98M ﹤0.01% 1448
2019
Q1
$3.96M Buy
88,369
+28,581
+48% +$1.44M 0.02% 583
2018
Q4
$2.87M Buy
59,788
+5,900
+11% +$358K 0.01% 637
2018
Q3
$3.6M Buy
53,888
+26,371
+96% +$1.47M 0.01% 619
2018
Q2
$1.29M Sell
27,517
-39,429
-59% -$2.17M 0.01% 1056
2018
Q1
$3.78M Buy
66,946
+11,179
+20% +$605K 0.01% 633
2017
Q4
$2.76M Sell
55,767
-2,765
-5% -$171K 0.01% 746
2017
Q3
$4.45M Sell
58,532
-4,387
-7% -$326K 0.02% 606
2017
Q2
$5.92M Sell
62,919
-2,854
-4% -$244K 0.02% 527
2017
Q1
$5.22M Buy
65,773
+32,532
+98% +$2.59M 0.02% 577
2016
Q4
$2.77M Hold
33,241
0.01% 762
2016
Q3
$3.72M Buy
33,241
+2,815
+9% +$311K 0.02% 654
2016
Q2
$3.37M Sell
30,426
-143
-0.5% -$17.4K 0.02% 687
2016
Q1
$3.19M Buy
30,569
+1,940
+7% +$150K 0.02% 710
2015
Q4
$2.31M Buy
28,629
+16,182
+130% +$1.29M 0.01% 772
2015
Q3
$863K Buy
12,447
+977
+9% +$85.1K ﹤0.01% 1095
2015
Q2
$1.12M Buy
+11,470
New +$1.23M 0.01% 1040

Other funds holding INO

Panagora Asset Management's INO Position: Q4 2019 in Review

Panagora Asset Management sold out of Inovio Pharmaceuticals (INO) in Q4 2019, closing a stake of 4,752 shares — an estimated $117K sold.

Panagora Asset Management first reported a position in INO in Q2 2015 and held it in 18 quarters. The position peaked at $5.92M in Q2 2017. 106 funds tracked by Wall St. Rank hold INO as of Q4 2019.

  • Panagora Asset Management reported no remaining Inovio Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Panagora Asset Management sold 4,752 Inovio Pharmaceuticals shares in Q4 2019, an estimated $117K.
  • Panagora Asset Management first reported a position in Inovio Pharmaceuticals in Q2 2015 and held it in 18 quarters.
  • Panagora Asset Management's Inovio Pharmaceuticals position peaked at $5.92M in Q2 2017.
  • 106 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2019.

Based on Panagora Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.